| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/19/2000 | EP0971913A1 Process for the production of semi synthetic statins via novel intermediates |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971879A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
| 01/19/2000 | EP0971744A2 COMBINATION THERAPY EMPLOYING ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS |
| 01/19/2000 | EP0971729A1 Therapeutic powder formulation for pulmonary administration, containing crystalline insulin |
| 01/19/2000 | EP0971712A1 Compositions for the inhibition of bone resorption |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/19/2000 | EP0809623B1 Alk(en)yl dicarboxylic acid bisesters, their use and method for preparing them |
| 01/19/2000 | EP0617962B1 Obesity inhibitor |
| 01/19/2000 | CN1241999A Vitamin D3 derivatives |
| 01/19/2000 | CN1241997A Nitromethylthiobenzene derivatives as inhibitors of aldose reductase |
| 01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
| 01/19/2000 | CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use |
| 01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015834 Administering chelate compound; antiischemic, antiepileptic, and wound healing agents; treating brain and nervous system disorders |
| 01/18/2000 | US6015821 Skin, psychological and cardiovascular disorders; anticarcinogenic, antiinflammatory and antidiabetic agents |
| 01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
| 01/18/2000 | US6015807 Protein kinase C inhibitor |
| 01/18/2000 | US6015804 Method of using tetracycline compounds to enhance interleukin-10 production |
| 01/18/2000 | US6015798 Mixture of omega-3 polyunsaturated fatty acids and arginine, cats and dogs |
| 01/18/2000 | US6015786 Method for increasing sex steroid levels using IGF or IGF/IGFBP-3 |
| 01/18/2000 | US6015713 Transgenic fish and a method of harvesting islet cells therefrom |
| 01/18/2000 | US6015678 Method for detection of a polynucleotide encoding protein kinase C inhibitor-homolog |
| 01/18/2000 | US6015558 Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-α function |
| 01/18/2000 | CA2136818C Sulfur-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 01/18/2000 | CA2010588C Substituted pyrimidine derivatives, their uses and a process for the preparation thereof |
| 01/18/2000 | CA2001124C Treatment of hypertension |
| 01/18/2000 | CA2001123C Treatment of osteoporosis |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001694A1 Paroxetine methanesulfonate |
| 01/13/2000 | WO2000001690A1 Cinnamic acid derivatives as cell adhesion molecules |
| 01/13/2000 | WO2000001687A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001662A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
| 01/13/2000 | WO2000001394A1 Biocompatible and biodegradable compositions containing hyaluronic acid and the derivatives thereof for the treatment of ulcers in the digestive apparatus |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO2000001238A1 Methods for eradication of nanobacteria |
| 01/13/2000 | WO1999059617A3 Immunoregulator |
| 01/13/2000 | WO1999053953A3 Methods and products related to metabolic interactions in disease |
| 01/13/2000 | WO1999046367A8 Methods of diagnosis and triage using cell activation measures |
| 01/13/2000 | WO1999038501A3 Method of regulating glucose metabolism, and reagents related thereto |
| 01/13/2000 | DE19830732A1 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff A composition comprising at least one lipid levels influencing drug |
| 01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
| 01/13/2000 | CA2658200A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336315A1 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/13/2000 | CA2335503A1 Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines |
| 01/12/2000 | EP0970957A1 Diaza-spiro[3,5] nonane derivatives |
| 01/12/2000 | EP0970955A1 Paroxetine methanesulfonate |
| 01/12/2000 | EP0970954A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 01/12/2000 | EP0970218A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof |
| 01/12/2000 | EP0970205A2 Human endosulfine gene |
| 01/12/2000 | EP0970095A1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase |
| 01/12/2000 | EP0970090A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 01/12/2000 | EP0970082A2 Biazacyclic crf antagonists |
| 01/12/2000 | EP0970077A1 Improved method for producing thiazolidinediones, and new thiazolidinediones |
| 01/12/2000 | EP0970053A1 5-oxysubstituted chinolines and their use as cholesterol ester transfer proteins inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0970036A1 Aryl- and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity |
| 01/12/2000 | EP0969865A1 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 01/12/2000 | EP0969860A1 Method for preparation of a therapeutic powder through coprecipitation of insulin and absorption enhancer |
| 01/12/2000 | EP0969852A1 Combination therapy for the treatment of diabetes and obesity |
| 01/12/2000 | EP0969835A1 Use of central cannabinoid receptor antagonists for regulating appetence |
| 01/12/2000 | EP0969827A1 Mixture of primary fatty acids obtained from sugar cane wax |
| 01/12/2000 | EP0969817A1 Dosage forms having improved release properties |
| 01/12/2000 | EP0639079B1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 01/12/2000 | CN1048247C Neuroprotective chroman compounds |
| 01/12/2000 | CN1048241C Vitamin D analogues, their preparing process, pharmaceutical composition contg. same and use thereof |
| 01/11/2000 | US6013792 Matrix metalloprotease inhibitors |
| 01/11/2000 | US6013665 Administering to a animal a triglyceride containg atleast 33 to 70 weight% medium acyl chain having 4 to 12 carbon atom, 30 to 67 weight % long acyl chain having more than 12 carbon atom, an equivalent carbon number 30 to 48 |
| 01/11/2000 | US6013647 Benzoxazinedione derivatives, method of producing them and uses thereof |
| 01/11/2000 | US6013645 Hypocholesterolemic, antiatherosclerotic and hypotriglyceridemic mercaptoacetylamide disulfide derivatives |
| 01/11/2000 | US6013622 Method of regulating appetite and metabolism |
| 01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
| 01/11/2000 | US6013454 Kinesin-like motor protein |
| 01/11/2000 | CA2018137C L-carnitine magnesium citrate |
| 01/07/2000 | CA2276791A1 Use of adenoviral e4 reading frames to improve expression of a gene of interest |
| 01/06/2000 | WO2000000596A1 3'-exonuclease, production and use thereof |
| 01/06/2000 | WO2000000587A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | WO2000000211A2 Hydrocolloids obtained from portulaca oleracea and the use thereof |
| 01/06/2000 | WO2000000189A1 Method for reducing the damaging effects of radiation therapy on animal skin and mucosa |
| 01/06/2000 | WO2000000039A1 Process and product for promoting weight loss in overweight dogs |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0969016A2 Glucagon-like peptide and insulinotropin derivates |
| 01/05/2000 | EP0968720A2 Gastric emptying-promoting composition |
| 01/05/2000 | EP0968719A2 Enzyme composition capable of forming an oligosaccharide in vivo |
| 01/05/2000 | EP0968228A1 Calcium phosphopeptide complexes |
| 01/05/2000 | EP0968226A1 G-rich oligo aptamers and methods of modulating an immune response |
| 01/05/2000 | EP0968209A1 THIAZOLE BENZENESULFONAMIDES AS $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY |
| 01/05/2000 | EP0968190A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/05/2000 | EP0968162A1 5-hydroxyalkyl substituted phenyls and their use in medicaments for the treatment of arteriosclerosis and hyperlipoproteinaemia |
| 01/05/2000 | EP0967892A1 Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 01/05/2000 | DE19828113A1 Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV Prodrugs of inhibitors of dipeptidyl peptidase IV |
| 01/05/2000 | CN1240445A Preparation of [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl] propyl] amino]-3H-imidazo [4,5-b] pyridin-3-y1]-n-ethyl-2 |
| 01/05/2000 | CN1048014C Substituted pyrroles compound and preparational process, medicinal compositions and use |